Stocks and Investing
Stocks and Investing
Tue, August 22, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Charles Duncan Reiterated (XENE) at Buy and Held Target at $58 on, Aug 22nd, 2023
Charles Duncan of Cantor Fitzgerald, Reiterated "Xenon Pharmaceuticals Inc." (XENE) at Buy and Held Target at $58 on, Aug 22nd, 2023.
Charles has made no other calls on XENE in the last 4 months.
There are 5 other peers that have a rating on XENE. Out of the 5 peers that are also analyzing XENE, 0 agree with Charles's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Charles
- Laura Chico of "Wedbush" Reiterated at Buy and Held Target at $47 on, Thursday, August 10th, 2023
- Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $50 on, Thursday, August 10th, 2023
- Brian Abrahams of "RBC Capital" Reiterated at Buy and Held Target at $51 on, Monday, July 17th, 2023
- Yatin Suneja of "Guggenheim" Reiterated at Strong Buy and Held Target at $49 on, Thursday, June 15th, 2023
- Tessa Romero of "JP Morgan" Maintained at Buy with Increased Target to $55 on, Tuesday, April 25th, 2023
Contributing Sources